InvestorsHub Logo
Followers 4
Posts 80
Boards Moderated 0
Alias Born 05/18/2020

Re: None

Friday, 08/07/2020 1:10:31 AM

Friday, August 07, 2020 1:10:31 AM

Post# of 232508
BLA-type submission planned this month in U.K. for HIV combination therapy with 350 mg weekly dose
• COVID-19 Phase 2 topline report to be submitted for consideration of emergency approval of leronlimab for patients with mild-to-moderate symptoms to U.K. and other countries following submission to the U.S. FDA next week

https://www.marketscreener.com/CYTODYN-INC-163210/news/CytoDyn-Seeks-UK-Approval-of-Leronlimab-for-HIV-and-COVID-19-31076230/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News